Member of the board of Diffchamb AB and other companies. Former Managing Director of Nobel Biocare and Business Unit Director at Astra
Stig Linder (1954), Board Member
Ph.D. Professor in Experimental Oncology at the Karolinska Institute, Solna. Extensive experience in anticancer drug research.
Hans Rosén (1960), Board Member, CEO
Former CEO Artimplant AB (Publ.), CEO Diffchamb AB (Publ.), CEO Cinventa AB, Marketing manager Chromogenix AB.
Bengt Ågerup (1943), Chairman
Ph.D. Founder of Q-Med. President and CEO of Q-Med 2003-2010. Chairman of Stockholm-
Uppsala Life Science, Board Member of the Swedish Foundation for Strategic Research.
Peter Nygren (1959), Board Member
MD, PhD. Professor in Oncology, Uppsala University Hospital. Extensive experience of clinical trials in oncology. Former assessor at the Swedish Medical Products Agency.
Allan Asp (1958), Board Member
Investment Manager, Innovationsbron AB. 25 years experience from the pharmaceutical/biotech industry. Inventor behind patents within DNA-seqeunsing.
MD, PhD. Former Medical Director of Glaxo Sweden and member of the corporate International Medical Board and Safety Board. Author of textbooks on clinical trial methodology.
Rolf Larsson (1957), Management
MD, PhD, Professor in Clinical Pharmacology at Uppsala University.
Gunnar Westman (1964), Management
Associate professor of organic chemistry at Chalmers University of Technology
Mårten Fryknäs (1974), Management
PhD, Master of Science in pharmacology. Extensive experience in cancer related bioinformatics and drug target discovery.
Joachim Gullbo (1971) Management
MD, PhD and Associate Professor in Experimental Clinical Pharmacology. Scientific background in pre-clinical development of anti-cancer drugs, from the early stages of lead identification, through evaluation to proof-of-concept in animal models.
Vivolux AB, Uppsala Science Park, Hus Oscar II, SE 751 83 Uppsala, Sweden. Phone +46 708 583470
